Styrax blocks inward and outward current of Kir2.1 channel.

Abstract

Kir2.1 plays key roles in setting rest membrane potential and modulation of cell excitability. Mutations of Kir2.1, such as D172N or E299V, inducing gain-of-function, can cause type3 short QT syndrome (SQT3) due to the enlarged outward currents. So far, there is no clinical drug target to block the currents of Kir2.1. Here, we identified a novel blocker of Kir2.1, styrax, which is a kind of natural compound selected from traditional Chinese medicine. Our data show that styrax can abolish the inward and outward currents of Kir2.1. The IC50 of styrax for WT, D172N and E299V are 0.0113 ± 0.00075, 0.0204 ± 0.0048 and 0.0122 ± 0.0012 (in volume), respectively. The results indicate that styrax can serve as a novel blocker for Kir2.1.

DOI: 10.1080/19336950.2016.1207022

Statistics

0500100015002017
Citations per Year

171 Citations

Semantic Scholar estimates that this publication has 171 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Ren2017StyraxBI, title={Styrax blocks inward and outward current of Kir2.1 channel.}, author={Shuxi Ren and Chunli Pang and Junwei Li and Yayue Huang and Suhua Zhang and Yong Zhan and Hailong An}, journal={Channels}, year={2017}, volume={11 1}, pages={46-54} }